Skip to content
Fowler Lab
Fowler Lab

Predicting antimicrobial resistance

  • News
  • Publications
  • Members
  • Research
    • Overview
    • Manifesto
    • Software
    • Reproducibility
  • Teaching
  • Contact
    • PhDs
  • Wiki
Fowler Lab
Fowler Lab

Predicting antimicrobial resistance

New publication: Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Philip Fowler, 13th January 202113th January 2021

A second Covid-19 publication I’m proud to be (a small) part of has recently published been in the New England Journal of Medicine. Given the Oxford University Hospital’s Staff Covid testing has been running for months, as described in our first publication, the team was able to show that having antibodies led to a substantially reduced-risk in being reinfected with SARS-CoV-2.

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon

Related

clinical microbiology publication

Post navigation

Previous post
Next post

Related Posts

antimicrobial resistance

Research position advertised

26th January 202126th January 2021

Come and work with me on antimicrobial resistance! Advert here. Broadly the idea is to…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More
antimicrobial resistance

New paper: predicting pyrazinamide resistance

20th March 202420th March 2024

This paper has finally been published and you can find it here. It had a…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More

SARS-CoV-2 pipeline live on EIT Pathogena

28th January 202528th January 2025

Back in the SARS-CoV-2 pandemic we worked closely with ORACLE Corp to build and deploy…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.

To find out more, including how to control cookies, see here: Cookie Policy
    ©2026 Fowler Lab | WordPress Theme by SuperbThemes